Induction of polymorphic 4'-hydroxylation of S-mephenytoin by rifampicin

Br J Clin Pharmacol. 1990 Sep;30(3):471-5. doi: 10.1111/j.1365-2125.1990.tb03799.x.


Studies were performed in 13 healthy subjects to determine whether treatment with rifampicin results in induction of the metabolism of mephenytoin. Daily dosing with 600 mg rifampicin for 22 days caused a three to eightfold increase in the 0-8 h urinary R/S ratio of mephenytoin following oral administration (100 mg) of racemic drug to extensive metabolizers of the anticonvulsant. This was accompanied by a 40 to 180% increase in the 0-8 h urinary excretion of the 4'-hydroxy metabolite. Four weeks after discontinuing rifampicin, both metabolic indices had returned to their baseline values. By contrast, rifampicin had no effect on either measures of metabolism in subjects of the poor metabolizer phenotype. Thus, it appears that the activity of the enzyme (P-450 MP) mediating the genetically determined 4'-hydroxylation of S-mephenytoin can be significantly modulated by enzyme inducing agents such as rifampicin and possibly environmental agents with a similar ability.

Publication types

  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Adult
  • Female
  • Humans
  • Hydroxylation / drug effects
  • Male
  • Mephenytoin / analogs & derivatives
  • Mephenytoin / metabolism*
  • Mephenytoin / urine
  • Middle Aged
  • Phenotype
  • Rifampin / pharmacology*


  • 4-hydroxymephenytoin
  • Mephenytoin
  • Rifampin